Related Experiment Video
Updated: May 4, 2026

05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
2.0K
Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure
Zongbin Liu1, Fei Huang2, Jinghui Du3
1Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, People's Republic of China.
Biomicrofluidics
|January 8, 2014
Summary
This study introduces a microfluidic device using deterministic lateral displacement (DLD) for fast, label-free separation of circulating tumor cells from blood. The optimized DLD arrays show high efficiency in isolating and enriching cancer cells for further studies.
Area of Science:
- Biomedical Engineering
- Microfluidics
- Cancer Cell Biology
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for cancer diagnosis and monitoring.
- Current methods for CTC isolation often require labeling or are inefficient.
- Microfluidic devices offer potential for precise cell manipulation.
Purpose of the Study:
- To develop and evaluate a microfluidic device for rapid, label-free isolation and enrichment of CTCs.
- To assess the efficiency of deterministic lateral displacement (DLD) arrays for cancer cell separation.
- To demonstrate the platform's utility in both cell solutions and whole blood samples.
Main Methods:
- Design and fabrication of a microfluidic device featuring deterministic lateral displacement (DLD) arrays.
- Utilizing size-dependent hydrodynamic forces for cell separation.
- Experimental validation and theoretical simulation of isolation efficiency for various cancer cell types.
- Testing both circular and triangular post array configurations.
Main Results:
- The microfluidic DLD device achieved high cancer cell isolation efficiency.
- Demonstrated significant enrichment factors for cancer cells from diluted blood samples.
- Both circular and triangular post arrays proved effective for cancer cell separation.
- The optimized DLD design enhanced performance.
Conclusions:
- The developed microfluidic DLD platform enables efficient and label-free separation of CTCs.
- This technology holds great promise for fundamental research and clinical applications involving CTCs.
- The device facilitates improved detection and analysis of circulating tumor cells.

